Jump to Main Content

Highlights of ASH in Asia-Pacific

Join global hematology leaders at Highlights of ASH in Asia-Pacific, a two-day program offered in Kuala Lumpur, Malaysia, to explore and discuss the most influential and novel research presented at the latest ASH annual meeting.

Highlights of ASH in Asia-Pacific




"I most enjoy the informal conversations with audience members after the talks, during breaks, etc. They are so enthusiastic about learning and always have challenging cases to discuss! I hope attendees appreciate the many ways that hematology intersects with women's health, and how hematologists can help improve the care of our patients through the life stages."

Sarah O'Brien, MD / Nationwide Children's Hospital
2025_HOA_AP_Speaker
HOA_AP_Attendees_2

Cutting-edge Research from Across Disciplines

Hear the most influential and novel research in malignant and classical hematology shared at the latest ASH annual meeting.

 

Instant Insights

Ask questions and get feedback from top hematology experts in real time.

 

Real Advice You Can Use

Gain insight into local and regional standards of care. Discover how emerging technology can enhance your practice.

 

Meet the World's Leading Hematology Experts

Get one-on-one interaction and tailored insights from leading experts in the field.

 

Career-Enhancing Networking and Mentorship Opportunities

Build partnerships, form new relationships, and reconnect with colleagues from your region.

Meeting Information




Program Schedule

This program is curated for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists. The following session topics correspond to the 2026 Highlights of ASH in Asia-Pacific and is subject to change.

8:00 – 8:45 a.m. Registration and Exhibits Open 
8:45 - 9:00 a.m. Welcome & Introductions
9:00 - 9:30 a.m. Changing Paradigms of Treatment Approaches for Acute Myeloid Leukemia

Katherine Tarlock, MD
University of Washington
Seattle, WA
9:30 - 10:00 a.m.   Integrating Approved Immunotherapies into Treatment Approaches for Adult B-Precursor Acute Lymphoblastic Leukemia

Adele K Fielding, MBBS, PhD
Hull York Medical School
Hull, England
10:00 - 10:30 a.m.  

Panel Discussion

10:30 - 11:00 a.m. Coffee Break in the Exhibit Hall
11:00 - 11:45 a.m. From Bench to Bedside: Innovations in Hemoglobinopathy Treatment Regional Realities, Global Innovations: Hemoglobinopathy Care in Asia Pacific

Payal Desai, MD
Wake Forest University
Winston-Salem, NC

Prantar Chakrabarti, MBBS, MD, DNB, DM
Zoho for Healthcare
Tenkasi, Tamil Nadu, India
11:45 a.m. - 12:15 p.m. Artificial Intelligence and Informatics in Hematology: Driving Practice Improvement and Patient-Centered Care

Barbara Lam, MD
Fred Hutchinson Cancer Center
Seattle, WA
12:15 - 12:45 p.m. Panel Discussion
12:45 - 2:00 p.m. Lunch in the Exhibit Hall (All Attendees) 
Lunch with the Experts (Ticketed)  
2:00 - 3:15 p.m. Tumor Board: Evolving Myeloma Treatment Paradigm: Applying New Evidence Across the Disease Continuum

Gin Gin Gan, MD
Universiti Malaya
Kuala Lumpur, Malaysia

Shaji Kumar, MD
Mayo Clinic
Rochester, MN

Hang Quach, MBBS, MD
St. Vincent's Hospital
Melbourne, Australia
3:15 - 3:45 p.m. Coffee Break in the Exhibit Hall 
3:45 - 4:15 p.m.   Clinical Features and Management of Histiocytic Neoplasms in the Era of Targeted Therapies

Gaurav Goyal, MD
University of Alabama
Birmingham, AL
4:15 - 4:45 p.m. Novel Insights and Emerging Therapies in Immune-Mediated Cytopenias: From PF4 Biology to Precision B-Cell Targeting

Michael A. Cole, MD, Dphil
Johns Hopkins Medicine
Baltimore, MD
4:45 - 5:15 p.m. Panel Discussion
5:15 - 5:20 p.m. Highlights of ASH Day 1 Closing Remarks   

8:00 – 8:45 a.m. Registration and Exhibits Open 
8:45 - 9:00 a.m. Welcome & Introductions
9:00 - 9:30 a.m. New Frontiers in Bleeding Disorders

Ross Baker, MBBS
Perth Blood Institute
Perth, Australia
9:30 - 10:00 a.m. Hematology Through a Gender Lens: Evolving Insights into Unique and Underrecognized Challenges in Hematology 

Sarah O’Brien, MD, MSc
Nationwide Children’s
Columbus, OH
10:00 - 10:30 a.m. Panel Discussion  
10:30 - 11:00 a.m. Coffee Break in the Exhibit Hall 
11:00 a.m. - 12:15 p.m. Turning the Tide: Key Cases and Conundrums in Thrombosis Medicine 

Lai Heng Lee, MBBS, MD
Singapore General Hospital
Singapore

Ponlapat Rojnuckarin, MD, PhD
Bumrungrad International Hospital
Bangkok, Thailand

Jeffrey Weitz, MD
McMaster University
Ontario, Canada
12:15 - 1:30 p.m. Lunch in the Exhibit Hall (All Attendees) 
Lunch with the Experts (Ticketed)  
1:30 - 2:00 p.m. Updates in Management of Indolent Lymphoma and Chronic Lymphocytic Leukemia

Jia Ruan, MD, PhD
Weill Cornell Medicine
New York, NY
2:00 - 2:45 p.m. Novel Treatment Strategies in Aggressive Lymphoma

Steven Park, MD
Wake Forest University
Winston-Salem, NC

Eric Tse, MBBS, PhD
Hong Kong University
Hong Kong
2:45 - 3:15 p.m. Panel Discussion
3:15 - 3:45 p.m. Coffee Break in the Exhibit Hall 
3:45 - 4:30 p.m. New Horizons in Transplantation and Cellular Therapies in Asia and Beyond

Robert Negrin, MD
Stanford University
Stanford, California

William Hwang, MBBS
National Cancer Center and Singapore General Hospital
Singapore
4:30 - 5:00 p.m. Practice Changing Advances in Myelodysplastic Syndromes and Myeloproliferative Neoplasms

Harry Gill Singh, MBBS
HKU Med
Hong Kong
5:00 - 5:30 p.m. Panel Discussion
5:30 p.m.   Highlights of ASH in Asia-Pacific Closing Remarks  


Program Coordinators

Program Co-Host

ASH is proud to co-host this meeting with the Malaysian Society of Hematology.

Program Co-Chairs

The Program Co-Chairs for the Highlights of ASH in Asia-Pacific are:

  • Malaysian Society of Hematology Program Co-Chairs
    • Dr. Gin Gin Gan 
    • Dr. Haris Abdul Rahman 
  • American Society of Hematology Program Co-Chairs
    • Dr. Payal Desai
    • Dr. Eric Tse